Integrated DNA Technologies advanced gene-editing safety workflows with UNCOVERseq, an off-target site nomination method designed to streamline the jump from high-throughput discovery to targeted confirmation. IDT said the approach, benchmarked in a Nature Communications study, increases the number of high-confidence sites relative to other methods and reports analytical sensitivity near 98%. UNCOVERseq builds on GUIDE-seq technology by using a redesigned tag aimed at reducing sequencing noise, enabling performance under cell-line and more promiscuous editing conditions. IDT’s rationale is to support a standardized, end-to-end off-target assessment process that better prioritizes the sites most likely to matter biologically. The update strengthens IDT’s positioning as a full-stack gene-editing services provider, which is increasingly critical as therapies move into settings where off-target characterization becomes a gating requirement for downstream development.